National Toxicology Program Board of Scientific Counselors; Announcement of Meeting; Request for Comments, 11724-11725 [2022-04389]
Download as PDF
11724
Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices
OMB control number 0910–0338; the
collections of information in §§ 201.56
and 201.57 for the content and format
requirements for labeling of human
prescription drug and biological
products have been approved under
OMB control number 0910–0572.
In addition, the following collections
of information in FDA’s guidances have
been approved by OMB (https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents):
• Collections in FDA’s draft guidance
for industry entitled ‘‘Formal Meetings
Between the FDA and Sponsors and
Applicants for PDUFA Products’’ have
been approved under OMB control
number 0910–0429.
• Collections in FDA’s guidance for
industry entitled ‘‘Special Protocol
Assessment’’ have been approved under
OMB control number 0910–0470.
• Collections in FDA’s guidance for
industry entitled ‘‘Establishment and
Operation of Clinical Trial Data
Monitoring Committees’’ have been
approved under OMB control number
0910–0581.
• Collections in FDA’s guidance for
industry entitled ‘‘Oversight of Clinical
Investigations—A Risk-Based Approach
to Monitoring’’ have been approved
under OMB control number 0910–0733.
• Collections in FDA’s guidance for
industry entitled ‘‘Expedited Programs
for Serious Conditions—Drugs and
Biologics’’ have been approved under
OMB control number 0910–0765.
• Collections in FDA’s guidance for
industry entitled ‘‘E6(R2) Good Clinical
Practice: Integrated Addendum to ICH
E6(R1)’’ have been approved under
OMB control number 0910–0843.
III. Electronic Access
lotter on DSK11XQN23PROD with NOTICES1
Persons with access to the internet
may obtain the guidance at https://
www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
vaccines-blood-biologics/guidancecompliance-regulatory-informationbiologics, https://www.fda.gov/
regulatory-information/search-fdaguidance-documents, or https://
www.regulations.gov.
Dated: February 24, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–04398 Filed 3–1–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Vaccines Federal
Implementation Plan
National Institutes of Health
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health, Office of Infectious Disease and
HIV/AIDS Policy.
AGENCY:
ACTION:
Notice.
17:34 Mar 01, 2022
The Department of Health and
Human Services’ Office of Infectious
Disease and HIV/AIDS Policy in the
Office of the Assistant Secretary for
Health announces that the draft
Vaccines Federal Implementation Plan
2021–2025 is available for public
comment. The Vaccines Federal
Implementation Plan is a companion
document to the Vaccines National
Strategic Plan 2021–2025 (VNSP),
which was published in January 2021.
The Vaccines Federal Implementation
Plan is a compilation of federal agency
immunization activities that collectively
advance the goals of the VNSP. Its target
audience is other federal agencies and
external partners who work in the area
of vaccination. The public will be
interested in how the implementation
plan documents federal agency efforts. It
does not outline mandates or other
COVID–19 response measures.
SUMMARY:
The public comment period for
the Vaccines Federal Implementation
Plan starts on February 28, 2022 at 9
a.m. ET and ends on March 29, 2022 at
5 p.m. ET. All comments must be
received by 5 p.m. ET on March 29,
2022 to be considered.
DATES:
All comments must be
submitted electronically to nvp.rfi@
hhs.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
David Kim, MD, MA, Director, Division
of Vaccines, Office of Infectious Disease
and HIV/AIDS Policy, Office of the
Assistant Secretary for Health, U.S.
Department of Health and Human
Services, Room L616, Switzer Building,
330 C St. SW, Washington, DC 20024.
Phone: 202–795–7697; Email: nvp.rfi@
hhs.gov.
Dated: February 17, 2022.
David Kim,
Designated Federal Officer, Vaccines Federal
Implementation Plan, Office of the Assistant
Secretary for Health.
[FR Doc. 2022–04327 Filed 3–1–22; 8:45 am]
Jkt 256001
PO 00000
Frm 00039
Fmt 4703
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This notice announces the
next meeting of the National Toxicology
Program (NTP) Board of Scientific
Counselors (BSC). The BSC, a federally
chartered, external advisory group
composed of scientists from the public
and private sectors, will review and
provide advice on programmatic
activities. This meeting is a virtual
meeting and is open to the public.
Written comments will be accepted and
registration is required to present oral
comments.
SUMMARY:
BILLING CODE 4150–44–P
VerDate Sep<11>2014
National Toxicology Program Board of
Scientific Counselors; Announcement
of Meeting; Request for Comments
Sfmt 4703
DATES:
Meeting: Scheduled for April 19,
2022, 12:30 p.m.–2:00 p.m. Eastern
Standard Time (EST). Ending times are
approximate; meeting may end earlier or
run later.
Written Public Comment
Submissions: Deadline is April 12, 2022.
Registration for Oral Comments:
Deadline is April 12, 2022.
ADDRESSES:
Meeting Web Page: The preliminary
agenda, registration, and other meeting
materials will be available at https://
ntp.niehs.nih.gov/go/165 by March 14,
2022.
Virtual Meeting: The URL for viewing
the virtual meeting will be provided on
the meeting web page the day before the
meeting.
FOR FURTHER INFORMATION CONTACT: Dr.
Mary Wolfe, Designated Federal Official
for the BSC, Office of Policy, Review,
and Outreach, Division of NTP, NIEHS,
P.O. Box 12233, K2–03, Research
Triangle Park, NC 27709. Phone: 984–
287–3209, Fax: 301–451–5759, Email:
wolfe@niehs.nih.gov. Hand Deliver/
Courier address: 530 Davis Drive, Room
K2130, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION: The BSC
will provide input to the NTP on
programmatic activities and issues. The
preliminary agenda topics include
presentations on a contract concept:
Bioinformatics Support for the NIEHS.
The preliminary agenda, roster of BSC
members, background materials, public
comments, and any additional
information, when available, will be
posted on the BSC meeting web page
(https://ntp.niehs.nih.gov/go/165) or
E:\FR\FM\02MRN1.SGM
02MRN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices
may be requested in hardcopy from the
Designated Federal Official for the BSC.
Following the meeting, summary
minutes will be prepared and made
available on the BSC meeting web page.
Meeting Attendance Registration: The
meeting is open to the public with time
scheduled for oral public comments.
Registration is not required to view the
virtual meeting; the URL for the virtual
meeting is provided on the BSC meeting
web page (https://ntp.niehs.nih.gov/go/
165) the day before the meeting. TTY
users should contact the Federal TTY
Relay Service at 800–877–8339.
Requests should be made at least five
business days in advance of the event.
Written Public Comments: NTP
invites written public comments.
Guidelines for public comments are
available at https://ntp.niehs.nih.gov/
ntp/about_ntp/guidelines_public_
comments_508.pdf.
The deadline for submission of
written comments is April 12, 2022.
Written public comments should be
submitted through the meeting web
page. Persons submitting written
comments should include name,
affiliation, mailing address, phone,
email, and sponsoring organization (if
any). Written comments received in
response to this notice will be posted on
the NTP web page, and the submitter
will be identified by name, affiliation,
and sponsoring organization (if any).
Oral Public Comment Registration:
The agenda allows for one formal public
comment period on the agenda topics
(up to 5 commenters total, up to 5
minutes per speaker per topic). Persons
wishing to make an oral comment are
required to register online at https://
ntp.niehs.nih.gov/go/165 by April 12,
2022. Oral comments will be received
only during the formal comment period
indicated on the preliminary agenda.
Oral comments will only be by
teleconference line. The access number
for the teleconference line will be
provided to registrants by email prior to
the meeting. Registration is on a firstcome, first-served basis. Each
organization is allowed one time slot
per topic. After the maximum number of
speakers is exceeded, individuals
registered to provide oral comment will
be placed on a wait list and notified
should an opening become available.
Commenters will be notified
approximately one week before the
meeting about the actual time allotted
per speaker.
If possible, oral public commenters
should send a copy of their slides and/
or statement or talking points to NTPMeetings@icf.com by April 12, 2022.
Meeting Materials: The preliminary
meeting agenda will be available on the
VerDate Sep<11>2014
17:34 Mar 01, 2022
Jkt 256001
meeting web page (https://ntp.niehs.
nih.gov/go/165) by March 14, 2022, and
will be updated one week before the
meeting. Individuals are encouraged to
access the meeting web page to stay
abreast of the most current information
regarding the meeting.
Background Information on the BSC:
The BSC is a technical advisory body
comprised of scientists from the public
and private sectors that provides
primary scientific oversight to the NTP.
Specifically, the BSC advises the NTP
on matters of scientific program content,
both present and future, and conducts
periodic review of the program for the
purpose of determining and advising on
the scientific merit of its activities and
their overall scientific quality. Its
members are selected from recognized
authorities knowledgeable in fields such
as toxicology, pharmacology, pathology,
epidemiology, risk assessment,
carcinogenesis, mutagenesis, cellular
biology, computational toxicology,
neurotoxicology, genetic toxicology,
reproductive toxicology or teratology,
and biostatistics. Members serve
overlapping terms of up to four years.
The BSC usually meets periodically.
The authority for the BSC is provided by
42 U.S.C. 217a, section 222 of the Public
Health Service Act (PHS), as amended.
The BSC is governed by the
provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C.
app.), which sets forth standards for the
formation and use of advisory
committees.
Dated: February 24, 2022.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2022–04389 Filed 3–1–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
11725
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Resource-Related
Research Projects (R24 Clinical Trial Not
Allowed).
Date: March 30, 2022.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G42,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Sandip Bhattacharyya,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G42,
Rockville, MD 20852, (240) 292–0189,
sandip.bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 24, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–04363 Filed 3–1–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Resource-Related
Research Projects (R24 Clinical Trial Not
Allowed).
Date: March 25, 2022.
Time: 1:00 p.m. to 3:00 p.m.
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 87, Number 41 (Wednesday, March 2, 2022)]
[Notices]
[Pages 11724-11725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04389]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Toxicology Program Board of Scientific Counselors;
Announcement of Meeting; Request for Comments
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the National
Toxicology Program (NTP) Board of Scientific Counselors (BSC). The BSC,
a federally chartered, external advisory group composed of scientists
from the public and private sectors, will review and provide advice on
programmatic activities. This meeting is a virtual meeting and is open
to the public. Written comments will be accepted and registration is
required to present oral comments.
DATES:
Meeting: Scheduled for April 19, 2022, 12:30 p.m.-2:00 p.m. Eastern
Standard Time (EST). Ending times are approximate; meeting may end
earlier or run later.
Written Public Comment Submissions: Deadline is April 12, 2022.
Registration for Oral Comments: Deadline is April 12, 2022.
ADDRESSES:
Meeting Web Page: The preliminary agenda, registration, and other
meeting materials will be available at https://ntp.niehs.nih.gov/go/165
by March 14, 2022.
Virtual Meeting: The URL for viewing the virtual meeting will be
provided on the meeting web page the day before the meeting.
FOR FURTHER INFORMATION CONTACT: Dr. Mary Wolfe, Designated Federal
Official for the BSC, Office of Policy, Review, and Outreach, Division
of NTP, NIEHS, P.O. Box 12233, K2-03, Research Triangle Park, NC 27709.
Phone: 984-287-3209, Fax: 301-451-5759, Email: [email protected].
Hand Deliver/Courier address: 530 Davis Drive, Room K2130, Morrisville,
NC 27560.
SUPPLEMENTARY INFORMATION: The BSC will provide input to the NTP on
programmatic activities and issues. The preliminary agenda topics
include presentations on a contract concept: Bioinformatics Support for
the NIEHS. The preliminary agenda, roster of BSC members, background
materials, public comments, and any additional information, when
available, will be posted on the BSC meeting web page (https://ntp.niehs.nih.gov/go/165) or
[[Page 11725]]
may be requested in hardcopy from the Designated Federal Official for
the BSC. Following the meeting, summary minutes will be prepared and
made available on the BSC meeting web page.
Meeting Attendance Registration: The meeting is open to the public
with time scheduled for oral public comments. Registration is not
required to view the virtual meeting; the URL for the virtual meeting
is provided on the BSC meeting web page (https://ntp.niehs.nih.gov/go/165) the day before the meeting. TTY users should contact the Federal
TTY Relay Service at 800-877-8339. Requests should be made at least
five business days in advance of the event.
Written Public Comments: NTP invites written public comments.
Guidelines for public comments are available at https://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf.
The deadline for submission of written comments is April 12, 2022.
Written public comments should be submitted through the meeting web
page. Persons submitting written comments should include name,
affiliation, mailing address, phone, email, and sponsoring organization
(if any). Written comments received in response to this notice will be
posted on the NTP web page, and the submitter will be identified by
name, affiliation, and sponsoring organization (if any).
Oral Public Comment Registration: The agenda allows for one formal
public comment period on the agenda topics (up to 5 commenters total,
up to 5 minutes per speaker per topic). Persons wishing to make an oral
comment are required to register online at https://ntp.niehs.nih.gov/go/165 by April 12, 2022. Oral comments will be received only during
the formal comment period indicated on the preliminary agenda. Oral
comments will only be by teleconference line. The access number for the
teleconference line will be provided to registrants by email prior to
the meeting. Registration is on a first-come, first-served basis. Each
organization is allowed one time slot per topic. After the maximum
number of speakers is exceeded, individuals registered to provide oral
comment will be placed on a wait list and notified should an opening
become available. Commenters will be notified approximately one week
before the meeting about the actual time allotted per speaker.
If possible, oral public commenters should send a copy of their
slides and/or statement or talking points to [email protected] by
April 12, 2022.
Meeting Materials: The preliminary meeting agenda will be available
on the meeting web page (https://ntp.niehs.nih.gov/go/165) by March 14,
2022, and will be updated one week before the meeting. Individuals are
encouraged to access the meeting web page to stay abreast of the most
current information regarding the meeting.
Background Information on the BSC: The BSC is a technical advisory
body comprised of scientists from the public and private sectors that
provides primary scientific oversight to the NTP. Specifically, the BSC
advises the NTP on matters of scientific program content, both present
and future, and conducts periodic review of the program for the purpose
of determining and advising on the scientific merit of its activities
and their overall scientific quality. Its members are selected from
recognized authorities knowledgeable in fields such as toxicology,
pharmacology, pathology, epidemiology, risk assessment, carcinogenesis,
mutagenesis, cellular biology, computational toxicology,
neurotoxicology, genetic toxicology, reproductive toxicology or
teratology, and biostatistics. Members serve overlapping terms of up to
four years. The BSC usually meets periodically. The authority for the
BSC is provided by 42 U.S.C. 217a, section 222 of the Public Health
Service Act (PHS), as amended.
The BSC is governed by the provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C. app.), which sets forth standards
for the formation and use of advisory committees.
Dated: February 24, 2022.
Brian R. Berridge,
Associate Director, National Toxicology Program.
[FR Doc. 2022-04389 Filed 3-1-22; 8:45 am]
BILLING CODE 4140-01-P